- Home
- PYPD vs COCH Comparison
PYPD vs COCH Comparison
Compare PYPD & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- COCH
- Stock Information
- Founded
- PYPD 2008
- COCH 1995
- Country
- PYPD Israel
- COCH United States
- Employees
- PYPD N/A
- COCH N/A
- Industry
- PYPD Medical/Dental Instruments
- COCH Blank Checks
- Sector
- PYPD Health Care
- COCH Finance
- Exchange
- PYPD Nasdaq
- COCH Nasdaq
- Market Cap
- PYPD 35.3M
- COCH 31.6M
- IPO Year
- PYPD 2020
- COCH N/A
- Fundamental
- Price
- PYPD $3.51
- COCH $1.55
- Analyst Decision
- PYPD Strong Buy
- COCH Strong Buy
- Analyst Count
- PYPD 5
- COCH 2
- Target Price
- PYPD $11.40
- COCH $9.25
- AVG Volume (30 Days)
- PYPD 1.4M
- COCH 21.8K
- Earning Date
- PYPD 08-13-2025
- COCH 08-11-2025
- Dividend Yield
- PYPD N/A
- COCH N/A
- EPS Growth
- PYPD N/A
- COCH N/A
- EPS
- PYPD N/A
- COCH N/A
- Revenue
- PYPD N/A
- COCH $212,000.00
- Revenue This Year
- PYPD N/A
- COCH $8.04
- Revenue Next Year
- PYPD N/A
- COCH $15.39
- P/E Ratio
- PYPD N/A
- COCH N/A
- Revenue Growth
- PYPD N/A
- COCH N/A
- 52 Week Low
- PYPD $2.30
- COCH $1.21
- 52 Week High
- PYPD $4.49
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- PYPD 56.85
- COCH 43.84
- Support Level
- PYPD $3.45
- COCH $1.36
- Resistance Level
- PYPD $3.62
- COCH $1.53
- Average True Range (ATR)
- PYPD 0.20
- COCH 0.08
- MACD
- PYPD -0.01
- COCH 0.00
- Stochastic Oscillator
- PYPD 63.57
- COCH 27.78
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.